Genetically predicted higher plasma omega-3 levels were associated with a lower risk of diabetic kidney disease (odds ratio 0.869), while omega-6 showed no significant association; a paired meta-analysis of 12 randomised trials (474 participants) found omega-3 supplementation lowered triglycerides, systolic blood pressure and a kidney injury marker, but did not improve albumin-to-creatinine ratio or estimated glomerular filtration rate.
What it shows: Genetic (Mendelian randomisation) analysis plus a meta-analysis of 12 small trials totalling only 474 participants in people with diabetic kidney disease; mediation findings were nominally significant only, and hard kidney-function outcomes did not shift.Study · FASEB J